Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma

Area of Science:

• Nuclear Medicine
• Oncology
• Diagnostic Imaging

Background:

• Malignant lymphomas are a significant group of cancers.
• Accurate detection and staging are crucial for effective treatment planning.
• Novel imaging modalities are continuously explored to improve diagnostic accuracy.

Purpose of the Study:

• To evaluate the efficacy of Technetium-99m tetrofosmin (Tc-TF) scintigraphy in detecting malignant lymphomas.
• To assess the diagnostic performance of Tc-TF scintigraphy in a cohort of lymphoma patients before chemotherapy.

Main Methods:

• Tc-TF scintigraphy was performed on 50 patients diagnosed with malignant lymphoma prior to chemotherapy.
• Patients received an intravenous injection of 20 mCi Tc-TF, with imaging conducted 10 minutes post-injection.

Main Results:

• Tc-TF scintigraphy successfully detected malignant lymphoma in 44 out of 50 patients, achieving an 88% detection rate.
• No significant differences in detection rates were observed based on patient demographics (sex, age) or lymphoma characteristics (Hodgkin vs. non-Hodgkin, stage, B symptoms).
• False-negative results (8%) were primarily associated with infradiaphragmatic malignant lymphoma.

Conclusions:

• Tc-TF scintigraphy demonstrates suitability as a diagnostic tool for malignant lymphoma.
• The imaging technique is particularly effective for detecting supradiaphragmatic lesions.
• Further investigation may be warranted for infradiaphragmatic disease assessment.